These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8741753)

  • 21. Apolipoprotein E epsilon4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence.
    Jelic V; Julin P; Shigeta M; Nordberg A; Lannfelt L; Winblad B; Wahlund LO
    J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):59-65. PubMed ID: 9221969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer's disease patients.
    Gabriel AJ; Almeida MR; Ribeiro MH; Durães J; Tábuas-Pereira M; Pinheiro AC; Pascoal R; Santana I; Baldeiras I
    Neurosci Lett; 2017 Feb; 641():101-106. PubMed ID: 28108398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population.
    Kim HC; Kim DK; Choi IJ; Kang KH; Yi SD; Park J; Park YN
    Psychiatry Clin Neurosci; 2001 Apr; 55(2):115-20. PubMed ID: 11285089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
    Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
    Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective effects of the APOE epsilon4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease.
    Lai MK; Tsang SW; Garcia-Alloza M; Minger SL; Nicoll JA; Esiri MM; Wong PT; Chen CP; Ramírez MJ; Francis PT
    Neurobiol Dis; 2006 Jun; 22(3):555-61. PubMed ID: 16473016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele.
    Cook DG; Leverenz JB; McMillan PJ; Kulstad JJ; Ericksen S; Roth RA; Schellenberg GD; Jin LW; Kovacina KS; Craft S
    Am J Pathol; 2003 Jan; 162(1):313-9. PubMed ID: 12507914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased CSF cortisol in AD is a function of APOE genotype.
    Peskind ER; Wilkinson CW; Petrie EC; Schellenberg GD; Raskind MA
    Neurology; 2001 Apr; 56(8):1094-8. PubMed ID: 11320185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease.
    Tapiola T; Lehtovirta M; Ramberg J; Helisalmi S; Linnaranta K; Riekkinen P; Soininen H
    Neurology; 1998 Jan; 50(1):169-74. PubMed ID: 9443475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.
    Myers RH; Schaefer EJ; Wilson PW; D'Agostino R; Ordovas JM; Espino A; Au R; White RF; Knoefel JE; Cobb JL; McNulty KA; Beiser A; Wolf PA
    Neurology; 1996 Mar; 46(3):673-7. PubMed ID: 8618665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of an apolipoprotein E epsilon4 allele is associated with increased parietal regional cerebral blood flow asymmetry in Alzheimer disease.
    van Dyck CH; Gelernter J; MacAvoy MG; Avery RA; Criden M; Okereke O; Varma P; Seibyl JP; Hoffer PB
    Arch Neurol; 1998 Nov; 55(11):1460-6. PubMed ID: 9823831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E epsilon4 allele frequency in vascular dementia.
    Davidson Y; Gibbons L; Purandare N; Byrne J; Hardicre J; Wren J; Payton A; Pendleton N; Horan M; Burns A; Mann DM
    Dement Geriatr Cogn Disord; 2006; 22(1):15-9. PubMed ID: 16645276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin metabolism in Alzheimer's disease differs according to apolipoprotein E genotype and gender.
    Craft S; Asthana S; Schellenberg G; Cherrier M; Baker LD; Newcomer J; Plymate S; Latendresse S; Petrova A; Raskind M; Peskind E; Lofgreen C; Grimwood K
    Neuroendocrinology; 1999 Aug; 70(2):146-52. PubMed ID: 10461029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of association of apolipoprotein E epsilon4 allele dose with cerebral glucose metabolism in Alzheimer disease.
    Hirono N; Mori E; Yasuda M; Ishii K; Ikejiri Y; Imamura T; Shimomura T; Hashimoto M; Yamashita H; Sasaki M
    Alzheimer Dis Assoc Disord; 1998 Dec; 12(4):362-7. PubMed ID: 9876966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ApoE alleles and tau markers in patients with different levels of cognitive impairment.
    Lavados M; Farías G; Rothhammer F; Guillon M; Mujica MC; Maccioni C; Maccioni RB
    Arch Med Res; 2005; 36(5):474-9. PubMed ID: 16099324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MPO and APOEepsilon4 polymorphisms interact to increase risk for AD in Finnish males.
    Reynolds WF; Hiltunen M; Pirskanen M; Mannermaa A; Helisalmi S; Lehtovirta M; Alafuzoff I; Soininen H
    Neurology; 2000 Nov; 55(9):1284-90. PubMed ID: 11087769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein E-epsilon 4 allele and familial risk in Alzheimer's disease.
    Li G; Silverman JM; Altstiel LD; Haroutunian V; Perl DP; Purohit D; Birstein S; Lantz M; Mohs RC; Davis KL
    Genet Epidemiol; 1996; 13(3):285-98. PubMed ID: 8797010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study of relationship between ApoE epsilon4 allele and hippocampal atrophy in Alzheimer disease].
    Li J; Kuang WH; Li J; Wang X; Huang MS; Wu DP
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):50-2. PubMed ID: 15702779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotype.
    Sjögren M; Hesse C; Basun H; Köl G; Thostrup H; Kilander L; Marcusson J; Edman A; Wallin A; Karlsson I; Troell M; Wachtmaister G; Ekdahl A; Olofsson H; Sandström A; Andreasen N; Minthon L; Blennow K
    J Neural Transm (Vienna); 2001; 108(4):451-8. PubMed ID: 11475012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele.
    Soininen H; Kosunen O; Helisalmi S; Mannermaa A; Paljärvi L; Talasniemi S; Ryynänen M; Riekkinen P
    Neurosci Lett; 1995 Mar; 187(2):79-82. PubMed ID: 7783963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.